SIALORRHEA
Clinical trials for SIALORRHEA explained in plain language.
Never miss a new study
Get alerted when new SIALORRHEA trials appear
Sign up with your email to follow new studies for SIALORRHEA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection shows promise for reducing excessive drooling
Symptom relief CompletedThis Phase 3 study tested whether injections of MYOBLOC (a botulinum toxin type B) into the salivary glands can safely reduce troublesome drooling in adults. 187 participants received either MYOBLOC or a placebo. The main goals were to measure changes in saliva flow and overall i…
Matched conditions: SIALORRHEA
Phase: PHASE3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC • Aim: Symptom relief
Last updated Jun 23, 2026 11:59 UTC
-
New drooling treatment shows promise in Year-Long study
Symptom relief CompletedThis study tested the safety and effectiveness of repeated MYOBLOC injections over one year in 187 adults with troublesome drooling caused by conditions like Parkinson's disease, stroke, or ALS. Participants received up to four treatment sessions, and researchers tracked side eff…
Matched conditions: SIALORRHEA
Phase: PHASE3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC • Aim: Symptom relief
Last updated Jun 22, 2026 12:05 UTC